by Raymond Tel | Aug 25, 2025 | News
There is another medical need application of the SUL-compound group with SUL-150, a compound closely related to SUL-238. Recently, a new scientific paper has been published in The International Journal of Molecular Sciences about the potential of SUL-150 as treatment...
by Raymond Tel | Oct 21, 2024 | News
We are happy to share great news! SUL-238 is currently in Phase I clinical trials in collaboration with our Turkish partner GEN Ilac. It is the first drug reported that leads to persisting improvement of vascular aging. This work has recently been published in The...
by Raymond Tel | Sep 10, 2024 | News
We are excited to announce that our lead drug candidate SUL-238 has been featured in the prestigious journal Nature Medicine. The article highlights hibernation as a source of inspiration for drug development, which also forms the basis for our groundbreaking...
by Raymond Tel | May 23, 2024 | News
https://open.spotify.com/episode/7sC62GDjmc0g2oQFu4XZo0...
